Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Allgeier SE Earnings Release 2012

Nov 16, 2012

28_rns_2012-11-16_6495fd1c-1a95-49d2-8226-b2a25f2ce36c.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Allgeier SE

Recommendation: BUY (BUY)

Risk: MEDIUM (MEDIUM) Price target: EUR 17.00 (17.00)

Solid 3Q figures – our FY 2012 estimates appear achievable

  • Allgeier SE reported solid 3Q figures today. Quarterly sales strongly increased by 13.8% YOY and reached EUR 107.7m (PY: 94.6m). We assume that TECOPS, which had been consolidated as of 1 September 2012, should have contributed about EUR 4m to 5m of sales in 3Q. In 9M 2012, sales amounted to EUR 297.8m (+12.1% compared to EUR 265.7m in 9M 2011).
  • Operating EBITA increased in 3Q 2012 by 15.6% YOY, from EUR 4.5m to EUR 5.2m. The corresponding EBITA margin remained at a constant level of 4.8% of sales. Operating EBITA is defined as earnings before interest, taxes and amortisation/impairments of assets from purchase price allocations (PPA) and effects on earnings from subsequent purchase price adjustments (earnouts). Subsequent purchase price adjustments can have significant impacts on EBITDA and EBIT. Acquired order balances and customer lists, in particular, are written off over a very short period and lead to a distortion of Allgeier's EBIT. The operating EBITA figure gives an idea of the level of Allgeier's EBIT margin after a stop of all M&A activities and the expiration of all earnouts and PPA amortisations.
  • In 3Q 2012, the Group's EBITDA reached only the previous year's level. In 9M 2012, however, EBITDA showed a solid growth of 7.4% YOY.
  • After the takeover of companies with strong customer bases and order books, the increased PPA amortisations reduced the quarterly EBIT to EUR 3.0m (PY: EUR 3.5m) and the 9M EBIT to EUR 6.3m (PY: EUR 8.7m). These amortisations, however, will continue to weigh on EBIT only for a few years. Net income and EPS therefore also showed a decline in 3Q and 9M 2012 (see page 2 for detailed figures).
  • Due to the seasonally stronger year-end business and the consolidation of TECOPS during the entire 4Q 2012, we believe that Allgeier is well on the way to achieving our FY 2012 estimates. We stick to our price target of EUR 17.00 and our BUY recommendation for the Allgeier share.
Y/E Dec 31, EUR m 2009 2010 2011 2012E 2013E 2014E
Sales 223.5 308.7 378.8 439.6 547.9 591.7
EBITDA 14.4 18.1 22.3 25.9 35.4 41.2
EBITA 12.8 15.6 19.0 18.8 27.2 34.4
EBIT 8.0 11.0 12.0 11.8 19.0 26.7
Net result 5.2 8.3 4.4 4.5 9.5 14.8
Basic EPS 0.60 0.99 0.52 0.54 1.13 1.76
Adjusted EPS 0.98 1.18 1.27 1.12 1.81 2.40
CPS 1.36 0.85 2.34 2.65 2.02 3.43
DPS 0.50 0.50 0.50 0.50 0.50 0.50
EBITDA margin 6.5% 5.9% 5.9% 5.9% 6.5% 7.0%
Adj. EBITDA margin n/a 5.7% 6.2% 5.9% 6.5% 7.0%
EBITA margin 5.7% 5.1% 5.0% 4.3% 5.0% 5.8%
EV/EBITDA 9.6 7.6 6.2 5.3 3.9 3.3
P/E 16.4 9.8 18.7 18.1 8.6 5.5
Source: CBS Research AG, Allgeier SE

16 November 2012

Short company profile:

Munich-based Allgeier SE is one of the leading consulting and service companies in the Germanspeaking region. With more than 2,600 employees and around 1,500 freelance IT experts, Allgeier offers its customers a complete service approach spanning design, implementation, and through to the operation of IT landscapes. Fifteen corporate units, each with its own specialist and sector-related focus, work together for more than 2,000 customers from almost all sectors.

Share data:
Share price (EUR, latest closing price): 9.75
Shares outstanding (m): 8.4
Market capitalisation (EUR m): 81.7
Enterprise value (EUR m): 138.0
Ø daily trading volume (3 m., no. of shares): 8,039
Performance data:
High 52 weeks (EUR): 12.89
Low 52 weeks (EUR): 9.30
Absolute performance (12 months): -11.0%
Relative performance vs. CDAX:
1 month -2.9%
3 months -10.0%
6 months -22.5%
12 months -22.9%
Shareholders:
Supervisory Board & Management Board: 42%
Own shares: 7%
Institutional investors: 9%
Other free float: 42%
Financial calendar:
-
Author:
Martin Decot (Analyst)
Close Brothers Seydler Research AG
Phone:
+49 (0) 69-977 84 56 0
Email:
[email protected]
www.cbseydlerresearch.ag

Please notice the information on the preparation of this document, the disclaimer, the advice regarding possible conflicts of interests, and the mandatory information required by § 34b WpHG (Securities Trading Law) at the end of this document. This financial analysis in accordance with § 34b WpHG is exclusively intended for distribution to individuals that buy or sell financial instruments at their own account or at the account of others in connection with their trading activities, occupation, or employment.

Appendix

Quarterly figures (YOY comparison)

IFRS EURm 3Q 2012 3Q 2011 Change 9M 2012 9M 2011 Change
Sales 107.7 94.6 14% 297.8 265.7 12%
YoY grow
th
13.8% 16.3% 12.1% 23.5%
Total output 108.4 96.4 12% 304.5 270.6 13%
Gross profit 52.3 41.1 27% 142.0 112.6 26%
as % of total output 48.3% 42.7% 46.6% 41.6%
EBITDA 6.1 6.1 0
%
16.1 14.9 7
%
as % of sales 5.7% 6.5% 5.4% 5.6%
Operating EBITA* 5.2 4.5 16% 13.0 12.0 8
%
as % of sales 4.8% 4.8% 4.4% 4.5%
EBIT 3.0 3.5 -15% 6.3 8.7 -27%
as % of sales 2.8% 3.7% 2.1% 3.3%
Net income attrib. to shareholders 1.5 1.7 -11% 1.2 4.3 -71%
Earnings per share (EUR) 0.18 0.20 -11% 0.15 0.51 -71%
Net financial debt (net cash) 50.6 11.9

* Operating EBITA: Earnings before interest, taxes and amortisation/impairments of assets from PPAs (goodwill, acquired order balances, customer lists, etc.) and effects on earnings from subsequent purchase price adjustments/earnouts Source: Allgeier SE, CBS Research AG

Profit and loss account

IFRS EURm 2008 2009 2010 2011 2012E 2013E 2014E
Sales
YoY grow
th
178.7
34.0%
223.5
25.1%
308.7
38.1%
378.8
22.7%
439.6
16.1%
547.9
24.6%
591.7
8.0%
Inventory changes (finished goods, WIP) 0.0 -0.1 0.0 0.3 0.1 0.2 0.2
Other own work capitalised 0.0 0.0 0.1 0.1 0.1 0.1 0.1
Total output 178.7 223.5 308.8 379.1 439.8 548.2 592.0
Cost of materials
as % of total output
-111.2
-62.2%
-137.5
-61.5%
-182.5
-59.1%
-220.2
-58.1%
-227.5
-51.7%
-250.5
-45.7%
-269.3
-45.5%
Gross profit
as % of total output
67.5
37.8%
86.0
38.5%
126.2
40.9%
158.9
41.9%
212.3
48.3%
297.7
54.3%
322.6
54.5%
Personnel expenses
as % of total output
-44.3
-24.8%
-59.5
-26.6%
-88.4
-28.6%
-109.0
-28.7%
-153.3
-34.8%
-219.5
-40.0%
-236.8
-40.0%
Other operating income
as % of total output
2.1
1.2%
4.0
1.8%
5.8
1.9%
6.6
1.7%
5.9
1.4%
4.4
0.8%
4.5
0.8%
Other operating expenses
as % of total output
-13.1
-7.3%
-16.1
-7.2%
-25.5
-8.2%
-34.2
-9.0%
-39.1
-8.9%
-47.1
-8.6%
-49.1
-8.3%
EBITDA
as % of total output
12.1
6.8%
14.4
6.5%
18.1
5.9%
22.3
5.9%
25.9
5.9%
35.4
6.5%
41.2
7.0%
Operating EBITA*
as % of total output
10.8
6.0%
12.8
5.7%
15.6
5.1%
19.0
5.0%
18.8
4.3%
27.2
5.0%
34.4
5.8%
Depreciation and amortization,
excl. goodwill impairments
as % of total output
Goodwill impairments
-4.3
-2.4%
-4.0
-4.1
-1.9%
-2.3
-7.0
-2.3%
0.0
-10.3
-2.7%
0.0
-14.1
-3.2%
0.0
-16.5
-3.0%
0.0
-14.5
-2.4%
0.0
as % of total output
EBIT
as % of total output
-2.2%
3.9
2.2%
-1.0%
8.0
3.6%
0.0%
11.0
3.6%
0.0%
12.0
3.2%
0.0%
11.8
2.7%
0.0%
19.0
3.5%
0.0%
26.7
4.5%
Interest income 3.1 0.8 0.7 0.4 0.4 0.2 0.1
Interest expenses -2.2 -1.8 -1.6 -2.9 -4.4 -4.2 -4.1
Result from sale of temping business 82.6 - - - - - -
EBT (Earnings before income taxes)
as % of total output
87.4
48.9%
7.0
3.2%
10.2
3.3%
9.5
2.5%
7.7
1.8%
15.0
2.7%
22.7
3.8%
Taxes on income
as % of EBT
-7.1
-8.1%
-2.1
-29.6%
-1.5
-14.4%
-4.2
-44.1%
-2.3
-30.0%
-4.5
-30.0%
-6.8
-30.0%
Net income of the group
as % of total output
80.4
45.0%
5.0
2.2%
8.7
2.8%
5.3
1.4%
5.4
1.2%
10.5
1.9%
15.9
2.7%
Minority interests -0.6 0.2 -0.4 -0.9 -0.9 -1.0 -1.1
Net income attributable to shareholders 79.7 5.2 8.3 4.4 4.5 9.5 14.8
Basic earnings per share (EUR) 8.93 0.60 0.99 0.52 0.54 1.13 1.76
Adjusted earnings per share (EUR)** 0.85 0.98 1.18 1.27 1.12 1.81 2.40

* Operating EBITA: Earnings before interest, taxes and amortisation/impairments of assets from PPAs (goodwill, acquired

order balances, customer lists, etc.) and effects on earnings from subsequent purchase price adjustments/earnouts

** Adjusted EPS = Adjusted net income divided by weighted average of shares outstanding;

Adjusted net income = Operating EBITA minus financial result minus assumed taxes (30% tax rate) minus minority interests. Source: CBS Research AG, Allgeier SE

Balance sheet

IFRS
EURm
2008 2009 2010 2011 2012E 2013E 2014E
Assets
Noncurrent assets 45.6 47.9 63.7 113.0 127.9 117.4 109.1
as % of total assets 23.6% 29.9% 31.2% 46.6% 42.7% 39.0% 35.2%
Intangible assets 41.9 42.3 57.4 102.8 117.3 107.0 97.6
Property, plant and equipment 3.4 4.6 5.4 8.8 10.2 10.1 11.2
Investments in companies consolidated at equity 0.0 0.4 0.0 0.0 0.0 0.0 0.0
Deferred taxes 0.3 0.5 1.0 1.4 0.4 0.3 0.3
Current assets 147.8 112.2 140.4 129.2 171.6 184.0 200.8
as % of total assets 76.4% 70.1% 68.8% 53.4% 57.3% 61.0% 64.8%
Inventories 1.0 2.7 3.1 3.0 3.8 4.1 4.3
Trade receivables 49.6 52.9 66.5 81.8 97.8 112.6 120.8
Other assets and receivables 28.1 7.4 9.5 12.4 17.2 15.5 16.3
Cash and cash equivalents 69.1 49.2 61.3 31.9 52.8 51.8 59.4
Total assets 193.4 160.1 204.1 242.1 299.6 301.4 309.9
Shareholders' equity and liabilities
Shareholders' equity
as % of total equity and liabilities
81.8
42.3%
79.5
49.7%
85.5
41.9%
88.2
36.4%
89.4
29.9%
95.7
31.8%
107.4
34.7%
Subscribed capital 9.1 9.1 9.1 9.1 9.1 9.1 9.1
Capital reserve 11.3 11.3 11.3 11.3 11.3 11.3 11.3
Retained earnings 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Own shares at acquisition cost -1.7 -3.6 -4.5 -5.2 -5.2 -5.2 -5.2
Profit carried forward -18.1 56.5 57.4 61.6 61.8 62.1 67.4
Net income for the year 79.7 5.2 8.3 4.4 4.5 9.5 14.8
Changes in equity recognised directly in equity -0.9 -0.9 -0.2 2.2 2.2 2.2 2.2
Minority interests 2.0 1.8 3.7 4.5 5.4 6.4 7.5
Noncurrent liabilities and deferred income
as % of total equity and liabilities
24.0
12.4%
23.8
14.9%
31.6
15.5%
35.5
14.7%
93.7
31.3%
86.4
28.7%
77.1
24.9%
Non-current profit-participation liabilities (PREPS) 13.0 13.0 6.0 0.0 0.0 0.0 0.0
Noncurrent financial liabilities incl. promissory notes 2.2 0.3 15.6 2.6 72.6 72.6 70.0
Provisions for pensions and similar obligations
Other noncurrent liabilities (mainly earnout
0.3 1.0 0.9 1.0 2.3 2.5 2.7
components from company acquisitions) 3.1 3.7 3.3 22.8 12.6 8.4 4.5
Deferred tax liabilities 5.5 5.8 5.7 9.2 6.1 2.8 -0.1
Current liabilities 87.6 56.7 87.0 118.4 116.5 119.3 125.4
as % of total equity and liabilities 45.3% 35.4% 42.6% 48.9% 38.9% 39.6% 40.5%
Current profit-participation liabilities (PREPS) 0.0 0.0 7.0 6.0 0.0 0.0 0.0
Current financial liabilities 13.4 8.4 16.9 32.7 11.4 12.0 12.0
Current provisions 13.1 7.8 10.8 16.1 21.6 21.9 23.7
Trade accounts payable 22.6 23.3 29.8 36.5 39.7 41.2 44.3
Prepayments received 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other liabilities incl. earnout
components from company acquisitions
38.5 17.3 22.5 27.1 43.7 44.2 45.4
Total equity and liabilities 193.4 160.1 204.1 242.1 299.6 301.4 309.9

Source: CBS Research AG, Allgeier SE

Cash flow statement

IFRS
EURm
2008 2009 2010 2011 2012E 2013E 2014E
EBIT 3.9 8.0 11.0 12.0 11.8 19.0 26.7
Depreciation and amortisation 8.3 6.4 7.0 10.3 14.1 16.5 14.5
Other non-cash income and expenses incl.
expenses from additions to provisions
4.0 4.2 6.7 10.0 9.0 9.9 10.4
Change in non-current provisions -0.4 0.1 0.0 0.0 1.4 0.2 0.2
Cash taxes paid/received -6.1 -4.7 -3.2 -3.8 -4.5 -7.6 -9.2
Cash flow from changes in working capital -13.3 -2.2 -14.5 -8.8 -9.5 -21.0 -13.8
Cash flow from operating activities -3.7 11.8 7.2 19.6 22.2 17.0 28.8
Net cash outflows from the purchase and
retirement of PP&E and intangible assets
-2.0 -1.6 -2.5 -4.2 -4.8 -6.1 -6.2
Payments for the purchase of subsidiaries and for
the acquisition of assets and rights
-17.0 -4.1 -8.7 -25.4 -28.2 0.0 0.0
Purchase price components paid for companies
acquired in other periods
0.0 -5.0 -0.9 -4.0 -3.1 -4.2 -3.9
Investments valued at equity (incl. disposals) 0.0 -0.2 0.3 -0.1 0.0 0.0 0.0
Payment balance from the sale of subsidiaries -5.4 0.0 0.0 0.0 0.0 0.0
Cash flow from investing activities 84.7 -16.3 -11.9 -33.7 -36.1 -10.2 -10.1
Payments for own shares -1.2 -1.9 -1.0 -1.1 0.0 0.0 0.0
Net borrowings/retirements of loans
and cash flow from promissory notes
-6.1 -4.1 17.4 -0.6 48.3 0.0 -2.6
Net cash inflow from ABS programme
(assignment of trade receivables)
3.8 -2.8 4.9 0.9 0.8 0.6 0.0
Repayment of profit-participation liabilities 0.0 0.0 0.0 -7.0 -6.0 0.0 0.0
Interests paid and received, net 1.0 -0.8 -0.7 -2.4 -4.0 -4.0 -4.0
Dividends paid -22.3 -5.2 -4.2 -4.2 -4.2 -4.2 -4.2
Payments to/from shareholders with non-controlling
interests and purchases of non-controlling interests
0.0 -0.1 -0.1 -0.9 -0.2 -0.2 -0.2
Cash flow from financing activities -24.9 -14.9 16.4 -15.2 34.7 -7.8 -11.1
Total change in cash and cash equivalents 56.1 -19.4 11.6 -29.3 20.9 -1.1 7.6
Currency-induced changes in cash and cash 0.0 0.0 0.3 -0.2 0.0 0.0 0.0
Cash and cash equivalents at the start of the period 12.5 68.6 49.1 61.1 31.6 52.5 51.4
Cash and cash equivalents at the end of the period 68.6 49.1 61.1 31.6 52.5 51.4 59.1
Bank overdraft 0.5 0.0 0.2 0.3 0.3 0.3 0.3
Cash and cash equivalents in the balance sheet 69.1 49.2 61.3 31.9 52.8 51.8 59.4

Source: CBS Research AG, Allgeier SE

Research

Schillerstrasse 27 - 29 60313 Frankfurt am Main

Phone: +49 (0)69 – 977 8456-0

Roger Peeters
Member of the Board
+49 (0)69 -977 8456- 12
[email protected]
Martin Decot +49 (0)69 -977 8456- 13
[email protected]
Igor Kim +49 (0)69 -977 8456- 15
[email protected]
Anna von Klopmann +49 (0)69 -977 8456- 10
[email protected]
Gennadij Kremer +49 (0)69 – 977 8456- 23
[email protected]
Daniel Kukalj +49 (0)69 – 977 8456- 21
[email protected]
Ralf Marinoni +49 (0)69 -977 8456- 17
[email protected]
Manuel Martin +49 (0)69 -977 8456- 16
[email protected]
Felix Parmantier +49 (0)69 -977 8456- 22
[email protected]
Marcus Silbe +49 (0)69 -977 8456- 14
[email protected]
Veysel Taze +49 (0)69 -977 8456- 18
[email protected]
Ivo Višić +49 (0)69 -977 8456- 19
[email protected]

Institutional Sales

Schillerstrasse 27 – 29 60313 Frankfurt am Main

Phone: +49 (0)69 – 9 20 54-400

Raimar Bock
Head of Sales
+49 (0)69 -9 20 54-115
[email protected]
Rüdiger Eich +49 (0)69 -9 20 54-119 Sule Erkan +49 (0)69 -9 20 54-107
(Germany, Switzerland) [email protected] (Sales-Support) [email protected]
Dr. James Jackson +49 (0)69 -9 20 54-113 Klaus Korzilius +49 (0)69 -9 20 54-114
(UK) [email protected] (Benelux, Germany) [email protected]
Stefan Krewinkel +49 (0)69 -9 20 54-118 Markus Laifle +49 (0)69 -9 20 54-120
(Execution, UK) [email protected] (Execution) [email protected]
Michael Laufenberg +49 (0)69 -9 20 54-112 Bruno de Lencquesaing +49 (0)69 -9 20 54-116
(Germany) [email protected] (Benelux, France) [email protected]
Angela Leser +49 (0)69 -9 20 54-111 Carsten Pfersdorf +49 (0)69 -9 20 54-168
(Fixed Income) [email protected] (Sales Trading) [email protected]
Carsten Schlegel +49 (0)69 -9 20 54-137 Christopher Seedorf +49 (0)69 -9 20 54-110
(Sales Trading) [email protected] (Sales-Support) [email protected]
Janine Theobald +49 (0)69 -9 20 54-106 Bas-Jan Walhof +49 (0)69 -9 20 54-105
(Austria, Germany) [email protected] (Benelux) [email protected]

Disclaimer and statement according to § 34b German Securities Trading Act ("Wertpapierhandelsgesetz") in combination with the provisions on financial analysis ("Finanzanalyseverordnung" FinAnV)

This report has been prepared independently of the company analysed by Close Brothers Seydler Research AG and/ or its cooperation partners and the analyst(s) mentioned on the front page (hereafter all are jointly and/or individually called the 'author'). None of Close Brothers Seydler Research AG, Close Brothers Seydler Bank AG or its cooperation partners, the Company or its shareholders has independently verified any of the information given in this document.

Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a security analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis.

Close Brothers Seydler Research AG is a majority owned subsidiary of Close Brothers Seydler Bank AG (hereafter ´CBS´). However, Close Brothers Seydler Research AG (hereafter ´CBSR´) provides its research work independent from CBS. CBS is offering a wide range of Services not only including investment banking services and liquidity providing services (designated sponsoring). CBS or CBSR may possess relations to the covered companies as follows (additional information and disclosures will be made available upon request):

  • a. CBS holds more than 5% interest in the capital stock of the company that is subject of the analysis.
  • b. CBS was a participant in the management of a (co)consortium in a selling agent function for the issuance of financial instruments, which themselves or their issuer is the subject of this financial analysis within the last twelve months.
  • c. CBS has provided investment banking and/or consulting services during the last 12 months for the company analysed for which compensation has been or will be paid for.
  • d. CBS acts as designated sponsor for the company's securities on the basis of an existing designated sponsorship contract. The services include the provision of bid and ask offers. Due to the designated sponsoring service agreement CBS may regularly possess shares of the company and receives a compensation and/ or provision for its services.
  • e. The designated sponsor service agreement includes a contractually agreed provision for research services.
  • f. CBSR and the analysed company have a contractual agreement about the preparation of research reports. CBSR receives a compensation in return.
  • g. CBS has a significant financial interest in relation to the company that is subject of this analysis.

In this report, the following conflicts of interests are given at the time, when the report has been published: d, f

CBS and/or its employees or clients may take positions in, and may make purchases and/ or sales as principal or agent in the securities or related financial instruments discussed in this analysis. CBS may provide investment banking, consulting, and/ or other services to and/ or serve as directors of the companies referred to in this analysis. No part of the authors compensation was, is or will be directly or indirectly related to the recommendations or views expressed.

Recommendation System:

Close Brothers Seydler Research AG uses a 3-level absolute share rating system. The ratings pertain to a time horizon of up to 12 months:

BUY: The expected performance of the share price is above +10%. HOLD: The expected performance of the share price is between 0% and +10%. SELL: The expected performance of the share price is below 0%.

Recommendation history over the last 12 months for the company analysed in this report:

Date Recommendation Price at change date Price target
13 March 2012 BUY (Initiating Coverage) EUR 11.80 EUR 19.00
20 April 2012 BUY EUR 11.75 EUR 19.00
10 May 2012 BUY EUR 11.60 EUR 19.00
6 July 2012 BUY EUR 10.70 EUR 19.00
6 August 2012 BUY EUR 10.52 EUR 19.00
8 August 2012 BUY EUR 10.59 EUR 19.00
31 August 2012 BUY EUR 10.76 EUR 19.00
4 September 2012 BUY EUR 10.65 EUR 17.00
16 November 2012 BUY EUR 9.75 EUR 17.00

Risk-scaling System:

Close Brothers Seydler Research AG uses a 3-level risk-scaling system. The ratings pertain to a time horizon of up to 12 months:

LOW: The volatility is expected to be lower than the volatility of the benchmark MEDIUM: The volatility is expected to be equal to the volatility of the benchmark HIGH: The volatility is expected to be higher than the volatility of the benchmark

The following valuation methods are used when valuing companies: Multiplier models (price/earnings, price/cash flow, price/book value, EV/Sales, EV/EBIT, EV/EBITA, EV/EBITDA), peer group comparisons, historical valuation approaches, discounting models (DCF, DDM), break-up value approaches or asset valuation approaches. The valuation models are dependent upon macroeconomic measures such as interest, currencies, raw materials and assumptions concerning the economy. In addition, market moods influence the valuation of companies. The figures taken from the income statement, the cash flow statement and the balance sheet upon which the evaluation of companies is based are estimates referring to given dates and therefore subject to risks. These may change at any time without prior notice.

The opinions and forecasts contained in this report are those of the author alone. Material sources of information for preparing this report are publications in domestic and foreign media such as information services (including but not limited to Reuters, VWD, Bloomberg, DPA-AFX), business press (including but not limited to Börsenzeitung, Handelsblatt, Frankfurter Allgemeine Zeitung, Financial Times), professional publications, published statistics, rating agencies as well as publications of the analysed issuers. Furthermore, discussions were held with the management for the purpose of preparing the analysis. Potentially parts of the analysis have been provided to the issuer prior to going to press; no significant changes were made afterwards, however. Any information in this report is based on data considered to be reliable, but no representations or guarantees are made by the author with regard to the accuracy or completeness of the data. The opinions and estimates contained herein constitute our best judgment at this date and time, and are subject to change without notice. Possible errors or incompleteness of the information do not constitute grounds for liability, neither with regard to indirect nor to direct or consequential damages. The views presented on the covered company accurately reflect the personal views of the author. All employees of the author's company who are involved with the preparation and/or the offering of financial analyzes are subject to internal compliance regulations.

The report is for information purposes, it is not intended to be and should not be construed as a recommendation, offer or solicitation to acquire, or dispose of, any of the securities mentioned in this report. Any reference to past performance should not be taken as indication of future performance. The author does not accept any liability whatsoever for any direct or consequential loss arising from any use of material contained in this report. The report is confidential and it is submitted to selected recipients only. The report is prepared for professional investors only and it is not intended for private investors. Consequently, it should not be distributed to any such persons. Also, the report may be communicated electronically before physical copies are available. It may not be reproduced (in whole or in part) to any other investment firm or any other individual person without the prior written approval from the author. The author is not registered in the United Kingdom nor with any U.S. regulatory body.

It has not been determined in advance whether and in what intervals this report will be updated. Unless otherwise stated current prices refer to the closing price of the previous trading day. Any reference to past performance should not be taken as indication of future performance. The author maintains the right to change his opinions without notice, i.e. the opinions given reflect the author's judgment on the date of this report.

This analysis is intended to provide information to assist institutional investors in making their own investment decisions, not to provide investment advice to any specific investor.

By accepting this report the recipient accepts that the above restrictions are binding. German law shall be applicable and court of jurisdiction for all disputes shall be Frankfurt am Main (Germany).

This report should be made available in the United States solely to investors that are (i) "major US institutional investors" (within the meaning of SEC Rule 15a-6 and applicable interpretations relating thereto) that are also "qualified institutional buyers" (QIBs) within the meaning of SEC Rule 144A promulgated by the United States Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the "Securities Act") or (ii) investors that are not "US Persons" within the meaning of Regulation S under the Securities Act and applicable interpretations relating thereto. The offer or sale of certain securities in the United States may be made to QIBs in reliance on Rule 144A. Such securities may include those offered and sold outside the United States in transactions intended to be exempt from registration pursuant to Regulation S. This report does not constitute in any way an offer or a solicitation of interest in any securities to be offered or sold pursuant to Regulation S. Any such securities may not be offered or sold to US Persons at this time and may be resold to US Persons only if such securities are registered under the Securities Act of 1933, as amended, and applicable state securities laws, or pursuant to an exemption from registration.

This publication is for distribution in or from the United Kingdom only to persons who are authorised persons or exempted persons within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom or any order made there under or to investment professionals as defined in Section 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and is not intended to be distributed or passed on, directly or indirectly, to any other class of persons.

This publication is for distribution in Canada only to pension funds, mutual funds, banks, asset managers and insurance companies.

The distribution of this publication in other jurisdictions may be restricted by law, and persons into whose possession this publication comes should inform themselves about, and observe, any such restrictions. In particular this publication may not be sent into or distributed, directly or indirectly, in Japan or to any resident thereof.

Responsible Supervisory Authority: Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin, Federal Financial Supervisory Authority) Graurheindorferstraße 108 53117 Bonn and Lurgiallee 12 60439 Frankfurt

Schillerstrasse 27 - 29 60313 Frankfurt am Main www.cbseydlerresearch.ag Tel.: 0049 - (0)69 - 97 78 45 60